20 November 2017
News and Views
Links and Services
The most recent issue of Gastroenterology examines the role of postmenopausal hormone therapy on risk of Crohn's disease and ulcerative colitis.
Estrogen has been proposed to modulate gut inflammation through an effect on estrogen receptors f
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors